Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Leukemia, Myelocytic, Acute
|
6892 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Lip and Oral Cavity Carcinoma
|
172 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.010 | 1 | 2014 | 2014 | ||||||
Malignant neoplasm of mouth
|
184 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.010 | 1 | 2014 | 2014 | ||||||
Malignant neoplasm of prostate
|
1082 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.030 | 1.000 | 3 | 2007 | 2015 | |||||
Prostate carcinoma
|
1168 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.030 | 1.000 | 3 | 2007 | 2015 | |||||
Congenital chromosomal disease
|
47 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Myocardial Infarction
|
680 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.010 | 1 | 2015 | 2015 | ||||||
Breast Carcinoma
|
2793 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.070 | 0.714 | 7 | 2003 | 2016 | |||||
Malignant neoplasm of breast
|
3417 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.070 | 0.714 | 7 | 2003 | 2016 | |||||
Malignant neoplasm of stomach
|
615 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.060 | 0.667 | 6 | 2002 | 2016 | |||||
Stomach Carcinoma
|
652 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.060 | 0.667 | 6 | 2002 | 2016 | |||||
Non-Small Cell Lung Carcinoma
|
712 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.040 | 0.750 | 4 | 2006 | 2016 | |||||
Xeroderma Pigmentosum, Complementation Group D
|
111 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.030 | 1.000 | 3 | 2007 | 2016 | |||||
Lymphoma, Non-Hodgkin
|
197 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.020 | 0.500 | 2 | 2009 | 2016 | |||||
Adult Myelodysplastic Syndrome
|
20 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Carcinoma of larynx
|
65 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Childhood Myelodysplastic Syndrome
|
20 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Malignant neoplasm of larynx
|
50 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
MYELODYSPLASTIC SYNDROME
|
95 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Squamous cell carcinoma of oropharynx
|
33 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Glioma
|
353 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.090 | 0.889 | 9 | 2012 | 2017 | |||||
Bladder Neoplasm
|
281 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.080 | 0.875 | 8 | 2007 | 2017 | |||||
Carcinoma of bladder
|
309 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.080 | 0.875 | 8 | 2007 | 2017 | |||||
Malignant neoplasm of urinary bladder
|
316 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.080 | 0.875 | 8 | 2007 | 2017 | |||||
cervical cancer
|
268 | 0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 | 0.050 | 0.200 | 5 | 2012 | 2017 |